October 21, 2021

Children with mild COVID-19 may not develop antibodies; oral vaccine booster shows promise in monkey study

A COVID-19 booster vaccine that can be given by mouth to people who already have antibodies from vaccination or prior infection has yielded promising results in monkeys and is likely to be tested soon in humans, according to the company developing it. A report of the study posted on Monday on bioRxiv ahead of peer review says Vyriad is working with the U.S. Food and Drug Administration to plan human trials.

Media Inquiries

For inquiries, please contact mediarelations@vyriad.com